James Forrest
Concepts (249)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhadinovirus | 8 | 2020 | 15 | 3.190 |
Why?
| Gammaherpesvirinae | 9 | 2018 | 18 | 2.770 |
Why?
| Viral Proteins | 9 | 2020 | 157 | 2.730 |
Why?
| Virus Replication | 14 | 2020 | 145 | 2.540 |
Why?
| Herpesviridae Infections | 9 | 2020 | 47 | 1.660 |
Why?
| Virus Latency | 14 | 2020 | 48 | 1.630 |
Why?
| Host-Pathogen Interactions | 4 | 2019 | 144 | 1.590 |
Why?
| Virus Activation | 9 | 2020 | 34 | 1.530 |
Why?
| Antigens, Viral | 5 | 2017 | 58 | 1.390 |
Why?
| B-Lymphocytes | 9 | 2020 | 172 | 1.320 |
Why?
| Immediate-Early Proteins | 2 | 2017 | 23 | 1.250 |
Why?
| Nuclear Proteins | 4 | 2017 | 249 | 1.230 |
Why?
| Trans-Activators | 2 | 2017 | 150 | 1.140 |
Why?
| Herpesvirus 8, Human | 5 | 2020 | 100 | 1.110 |
Why?
| Gene Expression Regulation, Viral | 8 | 2020 | 51 | 0.890 |
Why?
| Signal Transduction | 8 | 2019 | 1793 | 0.880 |
Why?
| Cytidine Deaminase | 1 | 2020 | 13 | 0.800 |
Why?
| Mice | 28 | 2020 | 6414 | 0.790 |
Why?
| Reoviridae | 7 | 2005 | 28 | 0.770 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2015 | 257 | 0.760 |
Why?
| Antigens, Nuclear | 1 | 2018 | 23 | 0.660 |
Why?
| Cell Line | 12 | 2017 | 1169 | 0.630 |
Why?
| Helper Viruses | 1 | 2017 | 6 | 0.620 |
Why?
| Animals | 32 | 2020 | 14624 | 0.620 |
Why?
| Codon | 1 | 2017 | 48 | 0.620 |
Why?
| Genetic Engineering | 1 | 2017 | 29 | 0.610 |
Why?
| Cell Adhesion Molecules | 8 | 2006 | 84 | 0.610 |
Why?
| Sarcoma, Kaposi | 3 | 2020 | 79 | 0.500 |
Why?
| Receptors, Virus | 6 | 2006 | 31 | 0.490 |
Why?
| Phosphoproteins | 1 | 2013 | 118 | 0.460 |
Why?
| Mice, Inbred C57BL | 8 | 2018 | 2028 | 0.450 |
Why?
| MAP Kinase Kinase 4 | 1 | 2012 | 34 | 0.450 |
Why?
| 3T3 Cells | 3 | 2018 | 52 | 0.450 |
Why?
| Models, Biological | 3 | 2013 | 840 | 0.420 |
Why?
| Tumor Virus Infections | 3 | 2017 | 42 | 0.410 |
Why?
| HEK293 Cells | 5 | 2019 | 249 | 0.400 |
Why?
| Herpesviridae | 3 | 2020 | 20 | 0.370 |
Why?
| Orthoreovirus, Mammalian | 4 | 2018 | 17 | 0.360 |
Why?
| Proviruses | 1 | 2008 | 2 | 0.340 |
Why?
| Virology | 1 | 2008 | 9 | 0.340 |
Why?
| Epstein-Barr Virus Infections | 2 | 2019 | 35 | 0.320 |
Why?
| Promoter Regions, Genetic | 4 | 2019 | 546 | 0.310 |
Why?
| Genome, Viral | 3 | 2020 | 100 | 0.300 |
Why?
| Capsid Proteins | 4 | 2018 | 24 | 0.300 |
Why?
| Antigens, Neoplasm | 1 | 2007 | 171 | 0.290 |
Why?
| DNA Damage | 1 | 2008 | 363 | 0.280 |
Why?
| Receptors, Cell Surface | 2 | 2003 | 137 | 0.280 |
Why?
| Antiviral Agents | 2 | 2019 | 189 | 0.280 |
Why?
| NIH 3T3 Cells | 3 | 2018 | 55 | 0.270 |
Why?
| Mutagenesis | 2 | 2018 | 75 | 0.270 |
Why?
| Herpesvirus 4, Human | 2 | 2019 | 40 | 0.260 |
Why?
| Neoplasm Proteins | 1 | 2007 | 365 | 0.260 |
Why?
| Fibroblasts | 5 | 2017 | 371 | 0.250 |
Why?
| Tandem Mass Spectrometry | 2 | 2013 | 257 | 0.210 |
Why?
| Cells, Cultured | 5 | 2020 | 1758 | 0.210 |
Why?
| DNA, Viral | 2 | 2020 | 144 | 0.200 |
Why?
| Protein Binding | 5 | 2015 | 750 | 0.200 |
Why?
| Antigens, CD19 | 1 | 2020 | 18 | 0.200 |
Why?
| Lymphoid Tissue | 1 | 2020 | 23 | 0.200 |
Why?
| Germinal Center | 1 | 2020 | 23 | 0.200 |
Why?
| Antigens, Bacterial | 1 | 2020 | 63 | 0.190 |
Why?
| Apoptosis | 6 | 2014 | 1323 | 0.190 |
Why?
| Histamine | 1 | 2019 | 28 | 0.190 |
Why?
| N-Acetylneuraminic Acid | 4 | 2003 | 16 | 0.190 |
Why?
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 7 | 0.180 |
Why?
| Cell Differentiation | 2 | 2020 | 728 | 0.180 |
Why?
| Gene Deletion | 2 | 2015 | 286 | 0.180 |
Why?
| Interferon Regulatory Factors | 1 | 2019 | 18 | 0.180 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2019 | 42 | 0.180 |
Why?
| Burkitt Lymphoma | 1 | 2019 | 28 | 0.180 |
Why?
| Humans | 23 | 2020 | 53836 | 0.170 |
Why?
| Interleukin-1beta | 2 | 2019 | 94 | 0.170 |
Why?
| Mycobacterium tuberculosis | 1 | 2020 | 212 | 0.170 |
Why?
| Chaperonin Containing TCP-1 | 1 | 2018 | 1 | 0.170 |
Why?
| Capsid | 1 | 2018 | 3 | 0.170 |
Why?
| Virus Assembly | 1 | 2018 | 5 | 0.170 |
Why?
| Embryo, Mammalian | 1 | 2018 | 73 | 0.160 |
Why?
| Gene Knock-In Techniques | 1 | 2017 | 31 | 0.160 |
Why?
| Organ Specificity | 1 | 2018 | 135 | 0.160 |
Why?
| Herpesvirus Vaccines | 1 | 2017 | 1 | 0.160 |
Why?
| Base Pairing | 1 | 2017 | 29 | 0.150 |
Why?
| Homologous Recombination | 1 | 2017 | 45 | 0.150 |
Why?
| Mammalian orthoreovirus 3 | 3 | 2006 | 13 | 0.150 |
Why?
| Mice, SCID | 1 | 2017 | 197 | 0.150 |
Why?
| Female | 5 | 2018 | 28727 | 0.140 |
Why?
| Cell Proliferation | 1 | 2020 | 1116 | 0.140 |
Why?
| Amino Acid Sequence | 4 | 2012 | 774 | 0.140 |
Why?
| Centrifugation | 1 | 2015 | 15 | 0.140 |
Why?
| Bacterial Proteins | 1 | 2020 | 463 | 0.140 |
Why?
| Spleen | 3 | 2015 | 189 | 0.140 |
Why?
| Protein Interaction Maps | 1 | 2015 | 24 | 0.140 |
Why?
| Molecular Sequence Data | 4 | 2012 | 994 | 0.140 |
Why?
| Immunoprecipitation | 1 | 2015 | 73 | 0.140 |
Why?
| Mice, Transgenic | 1 | 2018 | 705 | 0.140 |
Why?
| Isotope Labeling | 1 | 2015 | 62 | 0.140 |
Why?
| Caspase 1 | 1 | 2015 | 27 | 0.140 |
Why?
| HIV Infections | 1 | 2019 | 398 | 0.130 |
Why?
| Chronic Disease | 1 | 2018 | 623 | 0.130 |
Why?
| Murine hepatitis virus | 1 | 2014 | 17 | 0.130 |
Why?
| Coronavirus | 1 | 2014 | 16 | 0.130 |
Why?
| Cell Line, Tumor | 4 | 2020 | 1546 | 0.130 |
Why?
| Junctional Adhesion Molecules | 5 | 2006 | 5 | 0.130 |
Why?
| Inflammasomes | 1 | 2015 | 61 | 0.130 |
Why?
| Protein Processing, Post-Translational | 1 | 2015 | 174 | 0.130 |
Why?
| Caspases | 1 | 2015 | 146 | 0.130 |
Why?
| Computational Biology | 2 | 2013 | 229 | 0.130 |
Why?
| CHO Cells | 5 | 2006 | 125 | 0.130 |
Why?
| Reoviridae Infections | 2 | 2005 | 21 | 0.130 |
Why?
| Mass Spectrometry | 1 | 2015 | 315 | 0.130 |
Why?
| Small Molecule Libraries | 1 | 2014 | 72 | 0.130 |
Why?
| Cricetinae | 5 | 2006 | 210 | 0.130 |
Why?
| Phosphorylation | 1 | 2015 | 614 | 0.120 |
Why?
| Cyclin D | 1 | 2013 | 21 | 0.120 |
Why?
| Drug Discovery | 1 | 2014 | 90 | 0.120 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 82 | 0.120 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 134 | 0.110 |
Why?
| Algorithms | 1 | 2017 | 699 | 0.110 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 154 | 0.110 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2012 | 27 | 0.110 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2013 | 403 | 0.110 |
Why?
| Models, Molecular | 2 | 2003 | 426 | 0.110 |
Why?
| Proteome | 1 | 2013 | 171 | 0.110 |
Why?
| Proteomics | 1 | 2013 | 337 | 0.100 |
Why?
| Virus Integration | 1 | 2010 | 9 | 0.100 |
Why?
| Genes, Immediate-Early | 1 | 2010 | 10 | 0.100 |
Why?
| Flow Cytometry | 3 | 2014 | 553 | 0.090 |
Why?
| Transcriptome | 1 | 2012 | 350 | 0.090 |
Why?
| Transcription Initiation Site | 1 | 2008 | 13 | 0.090 |
Why?
| Toll-Like Receptors | 1 | 2008 | 24 | 0.090 |
Why?
| High-Throughput Screening Assays | 2 | 2019 | 39 | 0.090 |
Why?
| DNA | 1 | 2012 | 581 | 0.090 |
Why?
| Male | 3 | 2019 | 27633 | 0.090 |
Why?
| Transfection | 3 | 2006 | 417 | 0.080 |
Why?
| Etoposide | 1 | 2008 | 79 | 0.080 |
Why?
| Lung | 3 | 2020 | 512 | 0.080 |
Why?
| MART-1 Antigen | 1 | 2007 | 12 | 0.080 |
Why?
| Polymerase Chain Reaction | 2 | 2014 | 539 | 0.080 |
Why?
| Vero Cells | 1 | 2007 | 44 | 0.080 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 88 | 0.080 |
Why?
| Tight Junctions | 2 | 2005 | 28 | 0.080 |
Why?
| Green Fluorescent Proteins | 1 | 2007 | 106 | 0.080 |
Why?
| Endothelial Cells | 2 | 2020 | 295 | 0.080 |
Why?
| Mutation | 1 | 2013 | 1425 | 0.080 |
Why?
| Transcription, Genetic | 1 | 2008 | 438 | 0.080 |
Why?
| Dimerization | 2 | 2003 | 62 | 0.080 |
Why?
| Gene Expression Profiling | 1 | 2012 | 1138 | 0.070 |
Why?
| NF-kappa B p50 Subunit | 1 | 2005 | 16 | 0.070 |
Why?
| Protein Structure, Tertiary | 2 | 2003 | 288 | 0.070 |
Why?
| Phenotype | 3 | 2003 | 824 | 0.070 |
Why?
| Transcription Factors | 1 | 2008 | 633 | 0.060 |
Why?
| Macrophages | 3 | 2015 | 401 | 0.060 |
Why?
| HeLa Cells | 4 | 2006 | 288 | 0.060 |
Why?
| Cross-Linking Reagents | 1 | 2003 | 46 | 0.060 |
Why?
| Carbohydrate Metabolism | 1 | 2003 | 31 | 0.060 |
Why?
| Mice, Knockout | 3 | 2015 | 957 | 0.060 |
Why?
| Biliary Atresia | 1 | 2003 | 9 | 0.060 |
Why?
| Mutagenesis, Site-Directed | 1 | 2003 | 117 | 0.060 |
Why?
| Point Mutation | 1 | 2003 | 76 | 0.060 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 322 | 0.060 |
Why?
| Lymphocytes | 1 | 2003 | 171 | 0.060 |
Why?
| Structure-Activity Relationship | 1 | 2003 | 431 | 0.050 |
Why?
| Caco-2 Cells | 2 | 2018 | 52 | 0.050 |
Why?
| Membrane Fusion | 1 | 2000 | 11 | 0.050 |
Why?
| Receptors, Histamine | 1 | 2019 | 9 | 0.050 |
Why?
| Lymphocyte Activation | 2 | 2012 | 188 | 0.050 |
Why?
| Databases, Genetic | 1 | 2020 | 100 | 0.050 |
Why?
| HIV | 1 | 2019 | 26 | 0.050 |
Why?
| Tumor Escape | 1 | 2019 | 22 | 0.050 |
Why?
| Coinfection | 1 | 2019 | 32 | 0.040 |
Why?
| Virulence Factors | 1 | 2020 | 95 | 0.040 |
Why?
| Drug Evaluation, Preclinical | 1 | 2019 | 158 | 0.040 |
Why?
| Time Factors | 2 | 2003 | 3282 | 0.040 |
Why?
| Protein Folding | 1 | 2018 | 51 | 0.040 |
Why?
| RNA Interference | 1 | 2018 | 200 | 0.040 |
Why?
| RNA, Small Interfering | 1 | 2018 | 263 | 0.040 |
Why?
| Genes, Viral | 2 | 2006 | 43 | 0.040 |
Why?
| Caspases, Initiator | 1 | 2015 | 9 | 0.030 |
Why?
| Salmonella typhimurium | 1 | 2015 | 55 | 0.030 |
Why?
| Interferons | 1 | 2015 | 46 | 0.030 |
Why?
| Harringtonines | 1 | 2014 | 2 | 0.030 |
Why?
| Hexachlorophene | 1 | 2014 | 2 | 0.030 |
Why?
| Nitro Compounds | 1 | 2014 | 15 | 0.030 |
Why?
| Virus Internalization | 1 | 2014 | 20 | 0.030 |
Why?
| Luciferases | 1 | 2014 | 61 | 0.030 |
Why?
| Cohort Studies | 1 | 2019 | 1548 | 0.030 |
Why?
| Thiazoles | 1 | 2014 | 61 | 0.030 |
Why?
| Viral Load | 1 | 2014 | 86 | 0.030 |
Why?
| Receptors, Antigen, B-Cell | 1 | 2014 | 9 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 2 | 2005 | 180 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2015 | 197 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2019 | 1114 | 0.030 |
Why?
| Microscopy, Fluorescence | 1 | 2014 | 191 | 0.030 |
Why?
| Animals, Newborn | 2 | 2005 | 405 | 0.030 |
Why?
| Repression, Psychology | 1 | 2012 | 1 | 0.030 |
Why?
| Terminal Repeat Sequences | 1 | 2012 | 6 | 0.030 |
Why?
| Regulatory Elements, Transcriptional | 1 | 2012 | 8 | 0.030 |
Why?
| Blotting, Western | 1 | 2014 | 698 | 0.030 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2012 | 46 | 0.030 |
Why?
| Open Reading Frames | 1 | 2012 | 55 | 0.030 |
Why?
| Cell Survival | 1 | 2014 | 681 | 0.030 |
Why?
| Cluster Analysis | 1 | 2012 | 254 | 0.030 |
Why?
| Tumor Cells, Cultured | 2 | 2003 | 485 | 0.030 |
Why?
| Disease Models, Animal | 1 | 2017 | 1684 | 0.020 |
Why?
| Receptors, Interferon | 1 | 2010 | 5 | 0.020 |
Why?
| Administration, Intranasal | 1 | 2010 | 29 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 487 | 0.020 |
Why?
| Plasmids | 1 | 2010 | 183 | 0.020 |
Why?
| Immunity, Innate | 1 | 2010 | 111 | 0.020 |
Why?
| DNA-Binding Proteins | 1 | 2012 | 484 | 0.020 |
Why?
| Viral Plaque Assay | 1 | 2008 | 6 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2012 | 1306 | 0.020 |
Why?
| Cytopathogenic Effect, Viral | 1 | 2006 | 5 | 0.020 |
Why?
| Receptors, Fc | 1 | 2006 | 9 | 0.020 |
Why?
| Sequence Deletion | 1 | 2006 | 83 | 0.020 |
Why?
| DNA Methylation | 1 | 2010 | 579 | 0.020 |
Why?
| Interferon-beta | 1 | 2005 | 30 | 0.020 |
Why?
| In Situ Nick-End Labeling | 1 | 2005 | 67 | 0.020 |
Why?
| Antibodies, Viral | 1 | 2006 | 125 | 0.020 |
Why?
| Mammals | 1 | 2005 | 57 | 0.020 |
Why?
| Sequence Alignment | 1 | 2005 | 148 | 0.020 |
Why?
| DNA Primers | 1 | 2005 | 234 | 0.020 |
Why?
| Myocarditis | 1 | 2005 | 40 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2006 | 580 | 0.020 |
Why?
| Base Sequence | 1 | 2005 | 733 | 0.020 |
Why?
| Encephalitis, Viral | 1 | 2003 | 6 | 0.020 |
Why?
| Middle Aged | 1 | 2019 | 13217 | 0.010 |
Why?
| Intestines | 1 | 2005 | 211 | 0.010 |
Why?
| Intestinal Mucosa | 1 | 2005 | 289 | 0.010 |
Why?
| Adult | 1 | 2019 | 14303 | 0.010 |
Why?
| Bile Ducts | 1 | 2003 | 53 | 0.010 |
Why?
| Heart | 1 | 2005 | 352 | 0.010 |
Why?
| Virulence | 1 | 2003 | 196 | 0.010 |
Why?
| Myocardium | 1 | 2005 | 441 | 0.010 |
Why?
| Intercellular Junctions | 1 | 2001 | 8 | 0.010 |
Why?
| Genotype | 1 | 2003 | 615 | 0.010 |
Why?
| Chick Embryo | 1 | 2001 | 80 | 0.010 |
Why?
| COS Cells | 1 | 2001 | 70 | 0.010 |
Why?
| Gene Library | 1 | 2001 | 46 | 0.010 |
Why?
| Protein Conformation | 1 | 2001 | 226 | 0.010 |
Why?
| Surface Plasmon Resonance | 1 | 2000 | 25 | 0.010 |
Why?
| DNA, Complementary | 1 | 2001 | 150 | 0.010 |
Why?
| Biosensing Techniques | 1 | 2000 | 28 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2001 | 211 | 0.010 |
Why?
| Recombinant Fusion Proteins | 1 | 2001 | 206 | 0.010 |
Why?
| Cell Death | 1 | 2001 | 233 | 0.010 |
Why?
| NF-kappa B | 1 | 2001 | 339 | 0.010 |
Why?
| Kinetics | 1 | 2000 | 703 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2001 | 432 | 0.010 |
Why?
| Brain | 1 | 2005 | 1420 | 0.010 |
Why?
|
|
Forrest's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|